BeOne Medicines AG (ONC)

BeOne Medicines AG Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 4, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	38,952	19,667	18,862	22,843	27,843	23,494
Market Cap Growth	73.96%	4.27%	-17.43%	-17.96%	18.51%	131.83%
Enterprise Value	35,935	18,005	16,441	19,597	24,626	19,028
Last Close Price	352.00	184.71	180.36	219.94	270.93	258.39
PS Ratio	7.65	5.16	7.67	16.13	23.67	76.06
PB Ratio	9.43	5.90	5.33	5.21	4.54	6.07
P/TBV Ratio	9.58	5.99	5.42	5.26	4.58	6.08
P/OCF Ratio	49.60	-	-	-	-	-
EV/Sales Ratio	7.23	4.72	6.69	13.84	20.94	61.60
Debt / Equity Ratio	0.25	0.32	0.26	0.14	0.11	0.14
Asset Turnover	0.74	0.65	0.40	0.19	0.17	0.09
Inventory Turnover	1.43	1.30	1.09	1.09	0.99	23.18
Quick Ratio	2.09	1.51	1.97	3.22	4.45	4.40
Current Ratio	2.39	1.80	2.32	3.55	4.76	4.61
Return on Equity (ROE)	1.81%	-18.77%	-22.26%	-38.11%	-29.15%	-67.19%
Return on Assets (ROA)	1.69%	-6.07%	-12.40%	-15.00%	-12.72%	-28.73%
Return on Capital Employed (ROCE)	3.50%	-15.40%	-30.30%	-36.40%	-20.70%	-36.60%
Earnings Yield	0.18%	-3.28%	-4.67%	-8.77%	-5.24%	-6.92%
FCF Yield	1.40%	-3.22%	-9.12%	-7.98%	-5.61%	-5.96%
Buyback Yield / Dilution	-6.60%	-0.86%	-1.22%	-11.15%	-11.16%	-38.99%

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q